ZETAGEN THERAPEUTICS
ZetaGen Therapeutics is commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway. ZetaGen Therapeutics's goal is to halt cancer, reduce pain, and rebuild bones. The company's solution has the potential to revolutionize the treatment of bone-related injuries, operations, and diseases, resulting in better outcomes for both patients and doctors.
ZETAGEN THERAPEUTICS
Industry:
Health Care Medical Device Therapeutics
Founded:
2015-01-01
Address:
Syracuse, New York, United States
Country:
United States
Website Url:
http://www.zetagen.com
Total Employee:
11+
Status:
Active
Contact:
401-699-9402
Total Funding:
14.36 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt SSL By Default
Similar Organizations
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
flipMD
Connecting physicians to side gigs. Built by physicians for physicians.
InnaMed
Launching HomeLab, a gateway to personalized healthcare in the comfort and privacy of your home. Measure + Analyze + Enhance.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
OYS Mobility
OYS Mobility develops prosthetic technology that allows people with limb loss or deformity to access healthcare and assistive devices.
Pression
Medical device company improving blood flow volume body-wide using smart compression with initial focus on heart failure patients.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Zenflow
Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
Current Employees Featured
Founder
Investors List
Consolidated Investment Group
Consolidated Investment Group investment in Series B - ZetaGen Therapeutics
New York Ventures
New York Ventures investment in Series B - ZetaGen Therapeutics
New York Ventures
New York Ventures investment in Series B - ZetaGen Therapeutics
National Cancer Institute
National Cancer Institute investment in Grant - ZetaGen Therapeutics
MedTech Innovator
MedTech Innovator investment in Seed Round - ZetaGen Therapeutics
Official Site Inspections
http://www.zetagen.com
- Host name: server.beresponsive.ca
- IP address: 162.223.228.26
- Location: Toronto Canada
- Latitude: 43.6683
- Longitude: -79.4205
- Timezone: America/Toronto
- Postal: M6G
More informations about "ZetaGen Therapeutics"
Zetagen | Our Company | About Zetagen | Private Clinical-Stage …
Zetagen Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company dedicated to developing breakthrough therapies via local administration for … See details»
ZetaGen Therapeutics - Crunchbase Company Profile
ZetaGen Therapeutics may be growing as it successfully raised $9.79 million in a Series B funding round, which is a significant financial milestone indicating … See details»
Zetagen Therapeutics - LinkedIn
Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic ... See details»
ZetaGen Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
May 7, 2025 About Zetagen Therapeutics Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company dedicated to developing proprietary carriers … See details»
Zetagen Therapeutics Announces Successful Completion of …
May 6, 2025 Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company dedicated to developing breakthrough therapies via local … See details»
ZetaGen Company Profile - MedTech Innovator
ZetaGen’s first product, ZetaFuse™, is a drug-device combination product that has been designated as a device by FDA and utilizes components with well-established clinical safety … See details»
Zetagen Therapeutics - VentureRadar
"Zetagen Therapeutics is a clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic cancers to bone and other organs as … See details»
Zetagen Therapeutics Company Profile | Management and
Zetagen Therapeutics Profile and History Zetagen is a private, clinical-stage pharmaceutical company that develops innovative treatments for cancer and osteologic interventions. They … See details»
Zetagen | Home | Innovative Cancer Treatments & osteologic …
Zetagen is a private, clinical-stage pharmaceutical company developing innovative cancer treatments alongside osteologic interventions. See details»
ZetaGen Therapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for ZetaGen Therapeutics. Use the PitchBook Platform to explore the full profile. See details»
Zetagen Therapeutics Inc. Profile - Medical XPRT
Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic … See details»
Zetagen | Research Overview | Compassionate Use Access
The research behind Zetagen. Preclinical research resulting in a Breakthrough Device Designation award to ZetaMet for metastatic breast cancer See details»
ZetaGen Therapeutics - Contacts, Employees, Board Members, …
ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform. See details»
Zetagen Fights Breast Cancer Where it Lives… – Endpoints News
Jun 2, 2025 Zetagen Therapeutics, founded 2015, private clinical-stage biopharmaceutical company develops first-of-its-kind targeted therapies for primary and metastatic breast cancer. … See details»
Zetagen Therapeutics Expands IP Portfolio, Achieving a Milestone …
Jan 8, 2025 Zetagen Therapeutics announced it has received authorization from Health Canada to conduct a Phase 2a study of ZetaMet™ treating metastatic bone lesions. See details»
Zetagen Therapeutics Announces Peer-reviewed Publication of In …
Jun 17, 2025 Zetagen Therapeutics, a private, clinical-stage, biopharmaceutical company developing first-of-its-kind targeted therapies for primary and metastatic breast ... See details»
Zetagen | News | Keep up to date with the latest from Zetagen …
Zetagen | News | The latest Press Releases, Patent Information, Funding announcements about inductive biologic treatments from Zetagen. See details»
zenagen.com Reviews: Is this site a scam or legit?
Is zenagen.com legit? Is it secure or a scam? In this comprehensive review, we dissect its pros and cons and see if it’s a reputable source. See details»
Walk With You | Zetagen
At Zetagen, we do what we do because we commit to Walk with You. Our first “Compassionate Use” patient was Colleen Connor. This is her story: As we walked with Colleen, we journeyed … See details»
Inductive Biologic Inhibiting Bone Metastases - Zetagen
Zetagen has discovered and patented the discovery of a new molecular pathway of a well establish small molecule, as well as, novel carriers and NEW chemical entities. Through this … See details»